C. Oberhoff
Impact in
- Hematology top 5%
- Erythropoietin and Anemia Treatment
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
- Oncology 24
- Cancer Treatment and Pharmacology 9
- Cancer Cells and Metastasis 5
- HER2/EGFR in Cancer Research 5
- Hematology 15
- Erythropoietin and Anemia Treatment 7
- Blood Coagulation and Thrombosis Mechanisms 5
- Co-authors
- S. Seeber (10 shared papers)Thomas C. Lauenstein (1 shared paper)Christoph U. Herborn (1 shared paper)Susanne C. Goehde (1 shared paper)Jörg F. Debatin (1 shared paper)Jörg Barkhausen (1 shared paper)Stefan G. Ruehm (1 shared paper)A. E. Schindler (9 shared papers)
- Journals
- Annals of Oncology (5 papers)Breast Cancer Research and Treatment (3 papers)Archives of Gynecology and Obstetrics (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
C. Oberhoff
44 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 82
- Hematology 297
- Oncology 454
- Internal Medicine 42
- Cancer Research 164
- Genetics 104
Countries citing papers authored by C. Oberhoff
This map shows the geographic impact of C. Oberhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Oberhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Oberhoff more than expected).
Fields of papers citing papers by C. Oberhoff
This network shows the impact of papers produced by C. Oberhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Oberhoff. The network helps show where C. Oberhoff may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Oberhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 203 | |
| 2 | 1998 | 88 | |
| 3 | Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies. | 2000 | 88 |
| 4 | 2001 | 81 | |
| 5 | Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy. | 2003 | 66 |
| 6 | 2004 | 56 | |
| 7 | 1998 | 55 | |
| 8 | 2002 | 36 | |
| 9 | 1999 | 31 | |
| 10 | 2012 | 30 | |
| 11 | Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study. | 2011 | 29 |
| 12 | 2000 | 22 | |
| 13 | Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis. | 2006 | 21 |
| 14 | A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel. | 1999 | 20 |
| 15 | 2005 | 18 | |
| 16 | Hemostatic effects of two oral contraceptives containing low doses of ethinyl estradiol and either gestodene or norgestimate: an open, randomized, parallel-group study. | 1996 | 16 |
| 17 | 2013 | 15 | |
| 18 | 1998 | 14 | |
| 19 | Plasmatic haemostasis in gonadotrophin-releasing hormone analogue therapy: effects of leuprorelin acetate depot on coagulatory and fibrinolytic activities. | 1992 | 14 |
| 20 | Perioperative development of a thrombogenic risk profile in patients with carcinomas of the breast: a cause of increased thrombosis. | 2000 | 14 |
About C. Oberhoff
C. Oberhoff is a scholar working on Oncology, Hematology, Genetics, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Erythropoietin and Anemia Treatment (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers), Cancer Cells and Metastasis (5 papers), HER2/EGFR in Cancer Research (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Breast Cancer Treatment Studies (4 papers). The work is most often cited by research in Hematology (297 citations), Oncology (454 citations), Internal Medicine (42 citations), Cancer Research (164 citations) and Genetics (104 citations). C. Oberhoff has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include S. Seeber, Thomas C. Lauenstein, Christoph U. Herborn, Susanne C. Goehde, Jörg F. Debatin, Jörg Barkhausen, Stefan G. Ruehm, A. E. Schindler, Ralf A. Hilger and M. E. Scheulen. Their work appears in journals such as Annals of Oncology, Breast Cancer Research and Treatment, Archives of Gynecology and Obstetrics, Cancer Chemotherapy and Pharmacology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.